LRRK2

ADC Related

ADC Antibody ADC Cytotoxin ADC Linker ADCs Drug-Linker Conjugates for ADC
Angiogenesis

5-alpha Reductase ALK Bcr-Abl BTK EGFR FAK FLT3 HER-2 HIF Src Syk VDA VEGFR
Anti-infection

Antibiotic Arenavirus Bacterial CMV EBV Enterovirus Filovirus Fungal Gli HBV HCV HCV Protease HIV HSV Influenza Virus Parasite RABV Reverse Transcriptase RSV SARS-CoV TMV Virus Protease
Apoptosis

Apoptosis ASK Bcl-2 Caspase c-Myc c-RET Cytohesin DAPK Ferroptosis FKBP IAP Mdm2 p53 PD-1 PD-L1 PERK PKD Ras RIP kinase ROS Survivin Thymidylate Synthase TNF Receptor TNFa TRADD
Autophagy

Autophagy LRRK2 Mitophagy OGA ULK
Cell Cycle

Antifolate APC Aurora Kinase BMI-1 CDK Chk c-Myc Eukaryotic Initiation Factor G-quadruplex HDAC HSP Kinesin LIMK Mad2 Microtubule(Tubulin) Mps1 Nucleoside Antimetabolite/Analog Nur77 p21 PAK PERK PFKFB PLK PPAR Ras Rho ROCK SRPK TOPK Topoisomerase Wee1
Cytoskeletal Signaling

Arp2 3 Complex Bcr-Abl Cardiac Myosin Dynamin Gap Junction Protein HSP Integrin Kinesin Microtubule Associated MLCK Myosin PAK TACC3 Wntbeta-catenin
DNA Damage

ATM(ATR) CRISPR(Cas9) DNA alkylator DNA Stain DNA(RNA) Synthesis GAK HDAC HSP Nucleoside Antimetabolite(Analog) OGG1 p97 PARG PARP RAD51 RNR Sirtuin SMN Telomerase Topoisomerase
Endocrinology & Hormones

5-alpha Reductase ACE Adrenergic Receptor Androgen Receptor Aromatase Estrogenprogestogen Receptor Glucocorticoid Receptor GPR Mineralocorticoid Receptor RAAS THR TSH Receptor
Epigenetics

AMPK Aurora Kinase DNA Methyltransferase Epigenetic Reader Domain EZH1 2 HDAC HIF Histone Acetyltransferase Histone Demethylase Histone Methyltransferase JAK MAT MicroRNA MLL Pim PKC Protein Arginine Deiminase Sirtuin Small Interfering RNA (siRNA) SMYD

+MORE

LRRK2

LRRK2 related products

Cat No.	Product Name	CAS No.	Product Description
V3738	CZC-25146	1191911-26-8	CZC-25146 is a potent, selective, and metabolically stable LRRK2 inhibitor (Leucine-rich repeat kinase-2) with IC50 of 4.76 nM and 6.87 nM for wild type LRRK2 and G2019S LRRK2 respectively.
V3739	CZC-25146 HCl	1191911-26-8	CZC-25146 is a potent, selective, and metabolically stable LRRK2 inhibitor (Leucine-rich repeat kinase-2) with IC50 of 4.76 nM and 6.87 nM for wild type LRRK2 and G2019S LRRK2 respectively.
V2923	CZC-54252	1191911-27-9	CZC-54252 is a potent, selective, and metabolically stable LRRK2 inhibitor (Leucine-rich repeat kinase-2) with IC50 of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2 respectively.
V0773	GNE-7915	1351761-44-8	GNE-7915 (GNE 7915; GNE7915) is a novel,highly potent, selective, and brain-penetrant leucine-rich repeat kinase 2 (LRRK2) inhibitor with anti-PD (Parkinsons disease) activity.
V3835	GNE-7915 tosylate	2070015-00-6	GNE-7915 tosylate is a novel,highly potent, selective, and brain-penetrant leucine-rich repeat kinase 2 (LRRK2) inhibitor, with IC50 and Ki of 9 nM and 1 nM, respectively.
V0774	GNE-9605	1536200-31-3	GNE-9605 (GNE 9605; GNE9605) is a novel, brain-penetrant,highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor with anti-PD (Parkinsons disease) activity.
V0775	GSK2578215A	1285515-21-0	GSK2578215A (GSK-2578215A; GSK 2578215A;GSK-2578215 A) is a novel, highly potent and selective LRRK2 kinase inhibitor with anti-PD (Parkinsons disease) activity.
V88563	LRRK2-IN-13	3032733-17-5	LRRK2-IN-13 (Compound 13) is an inhibitor of LRRK2 (IC50=0.57 nM).
V0776	LRRK2-IN-1	1234480-84-2	LRRK2-IN-1 (LRRK2-IN 1; LRRK2 IN-1) is a novel, highly potent and selective inhibitor of leucine-rich repeat kinase 2 (LRRK2) with anti-PD (Parkinsons disease) activity.
V98092	Nictide	1159973-22-4	Nictide is a peptide substrate of LRRK2 (leucine-rich repeat protein kinase 2).
V2916	PF-06447475	1527473-33-1	PF-06447475 (PF06447475) is a novel, highly potent, selective and brain penetrable inhibitor ofLeucine rich repeat kinase 2 (LRRK2)with anti-PD activity.
V144232	RN277		RN277 is an LRRK2 type II kinase inhibitor.
V144233	RN341		RN341 is a specific type II kinase inhibitor that inhibits the activity of LRRK2 (IC50: 296 nM).
V145256	SRI-31255	905580-86-1	SRI-31255 is an orally effective LRRK2 inhibitor with IC50 values of 520 nM for wild-type (WT) and 427 nM for mutant G2019S.